Science & Technology

It's a clue about how buyers might get their hands on a sub-$30,000 EV truck.

The Summer Game Fest showcase has come and gone for 2026, so we've put down our favorite trailers of the giant lot.

The traditional banking industry has a long history of consortium blockchain systems that haven’t fared well.

A North Carolina software engineer already secured an accommodation allowing her to avoid using AI at work based on her religious beliefs.

Ahead of its premiere on Paramount+, 'Among Us' showrunner Owen Dennis discusses assembling its A-list cast and steering clear of making an adaptation reliant on dated memes.

As the whole market suffers, Zcash saw a 60% drop in the last two days.

One of the most popular stories in the Turtles franchise is coming to console and PC from a new developer.

Talk about masturbatory.

It's not exactly like having an IMAX in your living room, but it's still pretty cool.

Does the U.S. government need Anthropic more than it's willing to admit?

When archaeologists discovered a huge hoard of old helmets off the Spanish coast, they thought the helmets must be Roman. They were wrong.

This week, health officials reported the first known case of Borrelia mayonii in New York.

Milly Alcock stars, with a cameo from David Corenswet, in the DC Studios film arriving June 26.

It could be more than a year before Blue Origin's New Glenn is ready to fly again, but NASA has no intention of letting the Artemis timeline slip.

The Glitch animated YouTube series' long-awaited theatrical finale is currently outperforming 'Obsession.'

With its highly anticipated IPO around the corner, the company is balancing its long-held reputation as a leader in safety with the demands of its future shareholders.

Many of the people who made Pixar's latest just found out the biggest star in the world contributed a new song.

Head starred as fan-favorite Giles alongside Sarah Michelle Gellar on the cult-beloved TV series.

The S&P Dow Jones Indices is keeping rules in place that prevent SpaceX from quickly joining the S&P 500 after its IPO.

pEVAC-PS is the first experimental vaccine designed completely with AI to be tested in a human trial.